title: Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH).
abstract: Dopamine beta-hydroxylase (E.C. 1.14.17.1; protein abbreviation: DbetaH) catalyzes conversion of dopamine to norepinephrine. Previous work identified two expressed alleles of the gene encoding DbetaH (locus symbol DBH), containing either G or T at nucleotide position 910, resulting in specification by codon 304 of alanine (DBH*304A) or serine (DBH*304S), respectively. The current study employed denaturing gradient gel electrophoresis to identify these alleles, and after developing a PCR RFLP for rapid genotyping, estimated the frequencies of the alleles in African-Americans, European-Americans, and in several geographically dispersed populations (Mbuti, Danes, Adygei, Chinese, Japanese, Surui, Maya, and Nasioi). DBH*304A was the most common allele in all populations tested, with allele frequencies greater than 0.80 in each case. There was significant heterogeneity in allele frequency across population groups. The DBH*304S allele was most common in subjects of African descent, and least common in East Asians and individuals from indigenous populations of North and South America. The frequency of DBH*304S was significantly higher in African-Americans (0.16) than in European-Americans (0.06; P < 0.004). Of the four DBH*304S homozygotes observed, all were Europeans and three of the four were Danes. Based on empirical P-values generated by computer simulation, the observed proportions of DBH*304S homozygotes did not differ significantly from Hardy-Weinberg expectations in any of the populations after Bonferroni correction for multiple comparisons. The observation of significant heterogeneity in DBH*304S allele frequency across different population samples demonstrates the importance of controlling for population stratification in future studies testing for associations between DBH*304S and clinical phenotypes.
authors.affiliation: Department of Psychiatry, VA Connecticut Health Care System, West Haven 06516, USA.
authors.forename: J F
authors.initials: JF
authors.lastname: Cubells
authors.forename: K
authors.initials: K
authors.lastname: Kobayashi
authors.forename: T
authors.initials: T
authors.lastname: Nagatsu
authors.forename: K K
authors.initials: KK
authors.lastname: Kidd
authors.forename: J R
authors.initials: JR
authors.lastname: Kidd
authors.forename: F
authors.initials: F
authors.lastname: Calafell
authors.forename: H R
authors.initials: HR
authors.lastname: Kranzler
authors.forename: H
authors.initials: H
authors.lastname: Ichinose
authors.forename: J
authors.initials: J
authors.lastname: Gelernter
mesh_terms: D000483:Alleles; D001797:Blood Protein Electrophoresis; D018076:DNA, Complementary / Q000235:genetics; D004198:Disease Susceptibility; D004299:Dopamine beta-Hydroxylase / Q000097:blood / Q000235:genetics*; D005006:Ethnicity / Q000235:genetics*; D005787:Gene Frequency; D014644:Genetic Variation; D005838:Genotype; D006801:Humans; D010641:Phenotype; D017354:Point Mutation; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D012559:Schizophrenia / Q000235:genetics; D019966:Substance-Related Disorders / Q000235:genetics
chemical_list: D018076:DNA, Complementary; D004299:Dopamine beta-Hydroxylase